The identification of the principal risk factors involved in the molecular pathogenesis of primary HCC remains poorly understood. Further studies are needed in order to elucidate the complex underlying mechanisms of this com mon malignancy. The elucidation of new molecular and/or genetic targets should lead to the development of more efficacious treatment for patients with HCC.